OrthoPediatrics Corp expected to post a loss of 21 cents a share - Earnings Preview
OrthoPediatrics Corp KIDS.O is expected to show a rise in quarterly revenue when it reports results on October 27 for the period ending September 30 2026
The Warsaw Indiana Indiana-based company is expected to report a 11.8% increase in revenue to $68.497 million from $61.25 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for OrthoPediatrics Corp is for a loss of 21 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OrthoPediatrics Corp is $25.00, about 1.2% above its last closing price of $24.71
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2026 | -0.33 | -0.30 | -0.30 | Met | 0.8 |
Mar. 31 2026 | -0.46 | -0.47 | -0.45 | Beat | 4.9 |
Dec. 31 2025 | -0.33 | -0.34 | -0.43 | Missed | -27.9 |
Sep. 30 2025 | -0.24 | -0.26 | -0.50 | Missed | -93.4 |
Jun. 30 2025 | -0.32 | -0.30 | -0.30 | Met | 0.9 |
Mar. 31 2025 | -0.45 | -0.45 | -0.46 | Missed | -2.1 |
Dec. 31 2024 | -0.33 | -0.31 | -0.69 | Missed | -120.2 |
Sep. 30 2024 | -0.22 | -0.24 | -0.34 | Missed | -41.1 |
This summary was machine generated October 23 at 20:05 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)